SILENCE THERAP. SP.ADR/1 (XRP2) — Net Asset Momentum
SILENCE THERAP. SP.ADR/1 (XRP2) recorded a net asset momentum of -53.5% as of December 2025, with net assets of €62.30 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of SILENCE THERAP. SP.ADR/1 to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
SILENCE THERAP. SP.ADR/1 Net Asset Momentum (2021–2025)
This chart tracks SILENCE THERAP. SP.ADR/1's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -53.5%, with net assets of €62.30 Million EUR as of December 2025. Read XRP2 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for SILENCE THERAP. SP.ADR/1 (2021–2025)
The table below shows the complete annual net asset history for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of SILENCE THERAP. SP.ADR/1.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €62.30 Million | €131.44 Million | €69.14 Million | ▼ -53.5% |
| 2024 | €134.02 Million | €202.63 Million | €68.61 Million | ▲ +509.4% |
| 2023 | €21.99 Million | €119.45 Million | €97.45 Million | ▼ -17.7% |
| 2022 | €26.71 Million | €130.10 Million | €103.38 Million | ▲ +132.1% |
| 2021 | €11.51 Million | €129.83 Million | €118.32 Million | — |